Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen therapy and thrombotic risk.

Virginia M Miller1, Muthuvel Jayachandran, John A Heit

  • 1Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, United States. miller.virginia@mayo.edu

Pharmacology & Therapeutics
|February 14, 2006
PubMed
Summary

Hormone therapy can increase thrombosis risk, but identifying at-risk women remains challenging. Understanding interactions between vascular factors and hemostasis is key to preventing thrombotic events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma metabolites, blood-borne microvesicles, and history of preeclampsia as predictors of coronary artery calcification in postmenopausal women.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Association between central adiposity and cognitive domain function in recently postmenopausal women: an analysis from the KEEPS-Cog substudy of the Kronos Early Estrogen Preventive Study.

Menopause (New York, N.Y.)·2025
Same author

The Genetic Associations Between Kidney Stones, Obesity, Type 2 Diabetes, and Hypertension.

Mayo Clinic proceedings·2025
Same author

Long-term effects of 4 years of menopausal hormone therapy on white matter integrity.

Menopause (New York, N.Y.)·2025
Same author

Longitudinal Study of the Vascular Glycocalyx and Urinary Podocyte Markers During Pregnancy.

Journal of the American Heart Association·2025

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Endocrinology

Background:

  • Post-menopausal hormone therapy is associated with increased risk of venous thrombosis, myocardial infarction (MI), and ischemic stroke.
  • Current methods for identifying individuals at high risk for thrombosis are limited.
  • Thrombosis involves both vascular anomalies and hemostatic system responses.

Purpose of the Study:

  • To explore the complex pathophysiology of thrombosis.
  • To identify factors influencing individual susceptibility to thrombotic events.
  • To improve risk stratification for women considering hormone therapy.

Main Methods:

  • Investigating vascular anatomy and function.
  • Analyzing hemostasis system characteristics.

Related Experiment Videos

  • Considering genetic background, lifestyle, and environmental exposures influencing gene expression.

    • Main Results:

    • Thrombosis requires a combination of vascular and hemostatic factors.
    • Interactions among various factors contribute to an individual's thrombosis risk.
    • A comprehensive understanding of these interactions is currently lacking.

    Conclusions:

    • Defining the interplay between vascular anomalies, hemostasis, and individual risk factors is crucial.
    • Improved identification of at-risk individuals will enable personalized prevention strategies.
    • This knowledge can guide clinical decisions regarding hormone therapy and thrombosis prevention.